Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stabilizing the tear film by mimicking its innermost *mucin* layer addresses a fundamental cause of dry eye symptoms—poor adhesion/spreadability due to insufficient hydrophilicity. This approach either stimulates endogenous production/secretion of protective glycoproteins or supplements them with synthetic analogs possessing similar physicochemical properties. Such interventions improve comfort, reduce damage risk from desiccation/irritants, and restore visual clarity for patients suffering from various forms of dry eye disease.
Stimulates endogenous mucin production/secretion or provides exogenous mucoadhesive polymers to mimic natural mucin's properties, enhancing tear film stability and ocular surface hydration.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear Film Stabilization (Mimics Mucin Layer).